(VIANEWS) – Shares of NYXOAH (BEL 20: NYXH.BR) jumped by a staggering 31.53% in 21 sessions from €5.17 to €6.80 at 05:24 EST on Tuesday, following the last session’s upward trend. BEL 20 is jumping 0.99% to €3,807.06, after two successive sessions in a row of gains.
NYXOAH’s last close was €6.80, 63.24% under its 52-week high of €18.50.
About NYXOAH
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Earnings Per Share
As for profitability, NYXOAH has a trailing twelve months EPS of €-0.68.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -23.22%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 343.1%, now sitting on 3.08M for the twelve trailing months.
Volatility
NYXOAH’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.30%, a positive 1.00%, and a positive 2.27%.
NYXOAH’s highest amplitude of average volatility was 1.19% (last week), 3.02% (last month), and 2.27% (last quarter).
Moving Average
NYXOAH’s worth is way above its 50-day moving average of €5.34 and higher than its 200-day moving average of €6.72.
More news about NYXOAH (NYXH.BR).
